Showing 2,405 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Epidemiology

Russia Dismisses Data Showing World's 5th-Highest HIV Infection Rate

Editor's pick
The Moscow Times
8 December 2022
Injectable & long-acting HIV treatment

Pregnancy Outcomes on Long-Acting Antiretroviral

Editor's pick
Medscape (requires free registration)
6 December 2022
HIV treatment for children & young people

European Commission Grants Expanded Marketing Authorization for Gilead’s Biktarvy® for the Treatment of HIV in Pediatric Populations

Editor's pick
Gilead Sciences press release
29 November 2022
Injectable & long-acting HIV treatment

Botswana Introduces Injectable Antiretrovirals for HIV Treatment

Editor's pick
AllAfrica
23 November 2022
Climate change

'I missed a dose for the first time': How the KZN floods derailed HIV treatment

Editor's pick
Bhekisisa
17 November 2022
Climate change

How Climate Change Is Impacting People Living With HIV and Medication Access in South Africa

Editor's pick
TheBody
12 November 2022
Injectable & long-acting HIV treatment

Lenacapavir Shows Continued Promise for People With Drug-Resistant HIV

Editor's pick
POZ
10 November 2022
HIV treatment

IDWeek 2022 Study Bites: What’s New in HIV Antiretroviral Therapy

Editor's pick
TheBodyPro
10 November 2022
Adherence

Tenofovir Detected in Urine Predicts HIV Viral Rebound, Drug Resistance

Editor's pick
Infectious Disease Advisor
9 November 2022
Weight gain & lipodystrophy

Obesity Risk Higher With DTG Than Other Regimens in 3 Big African Trials

Editor's pick
NATAP
1 November 2022
Pharmaceutical industry

Long-suffering CytoDyn withdraws HIV approval application for leronlimab, blaming clinical research organization

Editor's pick
FierceBiotech
1 November 2022
Adherence

Do questionnaires, pill counts, or gadgets tell health staff if people with HIV are taking their drugs?

Editor's pick
Liverpool School of Tropical Medicine
31 October 2022
Ageing & HIV

Metabolic complications of newer HIV drugs in older people

Editor's pick
i-Base
31 October 2022
Antibody-based treatment

GSK's ViiV gives early look at HIV broadly neutralizing antibody's power, eyes long-acting combo trial

Editor's pick
FierceBiotech
28 October 2022
Starting treatment

Long-Term Results Confirm Benefits of Early HIV Treatment

Editor's pick
POZ
26 October 2022
Antibody-based treatment

ViiV Healthcare presents positive proof-of-concept findings for N6LS, an investigational, broadly neutralising antibody (bNAb) offering a potential new approach for the treatment of HIV

Editor's pick
ViiV press release
26 October 2022
People with limited treatment options

Lenacapavir: 75% Sub-50 Response at 52 Weeks Despite Heavy ART Experience

Editor's pick
NATAP
26 October 2022
The search for a cure

Danish-led study takes major step in pursuit of HIV cure

Editor's pick
EurekAlert
18 October 2022
Treatment for women

Standard Integrase Regimens Have Minimal Glucose Impact in Older Black Women

Editor's pick
NATAP
14 October 2022
Ageing & HIV

Biktarvy Could Be Long-Term Option for Older Adults With HIV

Editor's pick
Infectious Disease Special Edition
6 October 2022
PrEP science

For Patients Taking PrEP, Poor Adherence Drives HIV Seroconversions

Editor's pick
Physician's Weekly
5 October 2022
People with limited treatment options

FDA Approves Trogarzo for 30-Second IV Push, Simplifying HIV Treatment for Heavily Treatment-Experienced People

Editor's pick
Infectious Disease Special Edition
5 October 2022
Drug interactions & pharmacokinetics

Low levels of RPV-LA might explain failure with injectable ART despite perfect adherence

Editor's pick
i-Base
3 October 2022
New & experimental HIV treatments

5 FDA decisions to watch in the fourth quarter

Editor's pick
BioPharma Dive
3 October 2022